AWHL · Aspira Women's Health Inc.
$0.28
0.00 (-0.04%)
At close · Sep 2
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Given the above conditions, there is substantial doubt about our ability to continue as a going concern within one year after the date these consolidated interim financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$12.99M
Shares
46.63M
AWHL metrics
62 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.28
Market cap
$12.99M
Price action
19 metricsPrice change (1W)
+3.2%
Price change (30D)
-20.4%
Price change (3M)
-48.4%
Price change (6M)
-18.0%
Price change (YTD)
-55.8%
Price change (1Y)
-32.0%
Trailing year
Price change (5Y)
—
52-week high
$0.69
52-week low
$0.26
Change from 52-week high
-59.6%
Change from 52-week low
+7.2%
Annualized volatility
153.4%
Beta
1.6
RSI (14D)
39.2
Price vs SMA 50
-24.2%
Price vs SMA 200
-31.4%
Avg volume (3M)
25,150
Relative volume
0.1
Average dollar volume
$10,683
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
46.63M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
57.8×
reciprocal yield 1.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
54.8×
reciprocal yield 1.8%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-81.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
11.2×
reciprocal yield 8.9%
EV / revenue historical average (5Y)
11.2×
reciprocal yield 9.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2024-11-14
Profitability
9 metricsGross margin
2,252.5%
Operating margin
-3,094.6%
Trailing 12 months
Net margin
-4,486.5%
Gross profit (TTM)
$5.02M
Operating profit (TTM)
−$6.90M
Net income (TTM)
−$10.01M
Trailing 12 months
Diluted EPS (TTM)
$-0.31
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-89.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$223,000
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+24.4%
Year over year · more shares
Revenue CAGR (3Y)
-65.3%
Revenue CAGR (5Y)
-40.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-225.6%
Debt / equity
—
Current ratio
0.5
EBITDA (TTM)
−$6.73M
Free cash flow (TTM)
—
Quick ratio
0.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$683,000
Latest balance sheet
Cash & equivalents
$477,000
Total assets
$4.43M
Total debt
$1.16M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$4.56M
Capital expenditures (TTM)
$37,000
R&D (TTM)
$3.12M
SG&A (TTM)
—
Stock compensation (TTM)
$473,000
R&D / revenue
1,398.7%
Stock compensation / revenue
212.1%
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
17 / 100
Insider activity
2 metricsNet insider buying (90D)
$100,000
Insider-sentiment score
83 / 100
Risk flags
1 metricsGoing concern
Flagged